Gene · 1292
Papers1,708
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,708
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Large-scale GWAS of strabismus identifies risk loci and provides support for a link with maternal smoking. | Nat Commun | 2025 | 40849414 | PubTator, text mining | PubMed |
| Spatial transcriptomic analysis across histological subtypes reveals molecular heterogeneity and prognostic markers in early-stage lung adenocarcinoma. | Clin Transl Med | 2025 | 40847563 | PubTator, text mining | PubMed |
| Cell Surface Proteomics Reveals Hypoxia-Regulated Pathways in Cervical and Bladder Cancer. | Proteomes | 2025 | 40843709 | PubTator, text mining | PubMed |
| Contribution of HMGB1 to Keratinocyte inflammation in Recessive Dystrophic Epidermolysis Bullosa. | bioRxiv | 2025 | 40832291 | PubTator, text mining | PubMed |
| Collagen VI microfibril structure reveals mechanism for molecular assembly and clustering of inherited pathogenic mutations. | Nat Commun | 2025 | 40813585 | PubTator, text mining | PubMed |
| COL6A2 in clear cell renal cell carcinoma: a multifaceted driver of tumor progression, immune evasion, and drug sensitivity. | J Transl Med | 2025 | 40770761 | PubTator, text mining | PubMed |
| CytoAnalyst web platform facilitates comprehensive single cell RNA sequencing analysis. | Sci Rep | 2025 | 40770264 | PubTator, text mining | PubMed |
| A Novel LAMA2 Mutation (c.7412G>A) Was Found in a Chinese Patient With Congenital Muscular Dystrophy. | J Cell Mol Med | 2025 | 40751275 | PubTator, text mining | PubMed |
| Multimodal Evaluation of Bethlem Myopathy with the c.788G > A Variant in the COL6A1 Gene: a case report with genetic, ultrasonographic, and structural-functional discordance correlations. | Acta Myol | 2025 | 40626679 | PubTator, text mining | PubMed |
| Regulatory T cells and matrix-producing cancer associated fibroblasts contribute on the immune resistance and progression of prognosis related tumor subtypes in ccRCC. | Sci Rep | 2025 | 40596367 | PubTator, text mining | PubMed |
| Genome-Wide Association Study of Intraocular Pressure in Population-Based Cohorts in Japan: The Tohoku Medical Megabank Organization Eye Study. | Ophthalmol Sci | 2025 | 40584246 | PubTator, text mining | PubMed |
| A diet-driven metabolic dysfunction-associated steatohepatitis (MASH) mouse model resembles the corresponding human disease. | J Mol Histol | 2025 | 40392411 | PubTator, text mining | PubMed |
| Blood biochemical landscape and new insights into clinical decision-making for polycystic ovary syndrome in Chinese women: a prospective cohort study. | Front Endocrinol (Lausanne) | 2025 | 40375948 | PubTator, text mining | PubMed |
| Exploring the molecular mechanisms underlying intervertebral disc degeneration by analysing multiple datasets. | Sci Rep | 2025 | 40289127 | PubTator, text mining | PubMed |
| Inter- and intra-familial phenotypic variability of autosomal dominant collagen VI related disorder. | Neurol Sci | 2025 | 40189714 | PubTator, text mining | PubMed |
| Characterization of severe COL6-related dystrophy due to the recurrent variant COL6A1 c.930+189C>T. | Brain | 2025 | 40177858 | PubTator, text mining | PubMed |
| The Spatial Transcriptomic Atlas of Human Limbus and Vital Niche Microenvironment Regulating the Fate of Limbal Epithelial Stem Cells. | Invest Ophthalmol Vis Sci | 2025 | 40131296 | PubTator, text mining | PubMed |
| Regulatory role of miR-128-2-5p in serum exosomes on COL6A2 expression and postmenopausal osteoporosis. | Hum Mol Genet | 2025 | 39817546 | PubTator, text mining | PubMed |
| Suppressing the progression of bladder cancer using cyclovirobuxine D based on network pharmacology and bioinformatics approaches. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39797986 | PubTator, text mining | PubMed |
| A diagnostic signatures for intervertebral disc degeneration using TNFAIP6 and COL6A2 based on single-cell RNA-seq and bulk RNA-seq analyses. | Ann Med | 2025 | 39704340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1292/papers?page=4